Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups
- PMID: 27529519
- DOI: 10.1002/cncr.30220
Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups
Abstract
Background: To obtain better insight into the biology of acute myeloid leukemia (AML) in various age groups, this study focused on the genetic changes occurring during a lifetime.
Methods: This study analyzed the relation between age and genetics from birth to 100 years in 5564 patients with de novo AML diagnosed from 1998 to 2012 (1192 patients from nationwide pediatric studies [AML Berlin-Frankfurt-Münster studies 98 and 2004] and 4372 adults registered with the Munich Leukemia Laboratory).
Results: The frequencies of cytogenetic subgroups were age-dependent. Favorable subtypes (t(8;21), inv(16)/t(16;16), and t(15;17)) decreased in general from the pediatric age group (2 to < 18 years; 33%) to the oldest groups (<5% for > 70 years; P < .0001). Unfavorable cytogenetics (-7/del(7), -5/del(5q) or 5p, inv(3)/t(3;3), t(6;9), complex karyotype, 12p, 17p, and 11q23/mixed-lineage leukemia aberrations, excluding t(9;11)) were frequent (42%) in infants (<2 years), had a low frequency in children and young adults (<22%), and increased in frequency up to 36% in patients older than 85 years (P = .01). This was even more significant for complex karyotypes (P ≤ .0001), which also showed a strong increase in the absolute age-specific incidence with age. Interestingly, the frequency of 11q23 abnormalities decreased from infants to older patients. The proportion of clinically relevant molecular aberrations of CCAAT/enhancer binding protein α, nucleophosmin (NPM1), and NPM1/fms-related tyrosine kinase 3-internal tandem duplication increased with age.
Conclusions: Altogether, with the exclusion of infants, a significant decrease in the proportion of favorable cytogenetic subtypes and an increase in unfavorable cytogenetics were observed with increasing age. These findings indicate different mechanisms for the pathogenesis of AML; these different mechanisms also suggest directions for etiological research and contribute to the more unfavorable prognosis with increasing age. Cancer 2016;122:3821-3830. © 2016 American Cancer Society.
Keywords: acute myeloid leukemia; adults; age groups; cytogenetics; molecular genetics; pediatric.
© 2016 American Cancer Society.
Similar articles
-
Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia.Hematology. 2012 Jan;17(1):9-14. doi: 10.1179/102453312X13221316477417. Hematology. 2012. PMID: 22549442
-
Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.J Clin Oncol. 2010 Jun 1;28(16):2682-9. doi: 10.1200/JCO.2009.25.6321. Epub 2010 May 3. J Clin Oncol. 2010. PMID: 20439630 Clinical Trial.
-
Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.J Clin Oncol. 2010 Jun 1;28(16):2674-81. doi: 10.1200/JCO.2009.24.8997. Epub 2010 May 3. J Clin Oncol. 2010. PMID: 20439644
-
[Advances of study on prognostic factors of molecular biology in acute myeloid leukemia with normal cytogenetics].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):1063-8. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 20723330 Review. Chinese.
-
Cytogenetics of pediatric acute myeloid leukemia.Eur J Haematol. 2009 Nov;83(5):391-405. doi: 10.1111/j.1600-0609.2009.01308.x. Epub 2009 Jun 25. Eur J Haematol. 2009. PMID: 19563518 Review.
Cited by
-
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.Blood Adv. 2024 Jun 25;8(12):3200-3213. doi: 10.1182/bloodadvances.2023011771. Blood Adv. 2024. PMID: 38621200 Free PMC article.
-
The Prenatal Origin of Childhood Leukemia: Potential Applications for Epidemiology and Newborn Screening.Front Pediatr. 2021 Apr 23;9:639479. doi: 10.3389/fped.2021.639479. eCollection 2021. Front Pediatr. 2021. PMID: 33968846 Free PMC article. Review.
-
The RUNX1/RUNX1T1 network: translating insights into therapeutic options.Exp Hematol. 2021 Feb;94:1-10. doi: 10.1016/j.exphem.2020.11.005. Epub 2020 Nov 17. Exp Hematol. 2021. PMID: 33217477 Free PMC article. Review.
-
Increasing Complexity of Molecular Landscapes in Human Hematopoietic Stem and Progenitor Cells during Development and Aging.Int J Mol Sci. 2022 Mar 27;23(7):3675. doi: 10.3390/ijms23073675. Int J Mol Sci. 2022. PMID: 35409034 Free PMC article. Review.
-
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors.Cancers (Basel). 2023 Jul 6;15(13):3512. doi: 10.3390/cancers15133512. Cancers (Basel). 2023. PMID: 37444622 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous